A study on the association between the severity of newly diagnosed obstructive sleep apnea and subclinical carotid atherosclerosis in patients without overt cardiovascular disease

Dimosthenis Lykouras (Patra, Greece), Kleanthis Theodoropoulos, Dimosthenis Lykouras, Kiriakos Karkoulias, Dushyant Damania, Aspasia Rigopoulou, George Hahalis, Ioannis Starakis, Kostas Spiropoulos

Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Session: Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Session type: Thematic Poster
Number: 2301
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Dimosthenis Lykouras (Patra, Greece), Kleanthis Theodoropoulos, Dimosthenis Lykouras, Kiriakos Karkoulias, Dushyant Damania, Aspasia Rigopoulou, George Hahalis, Ioannis Starakis, Kostas Spiropoulos. A study on the association between the severity of newly diagnosed obstructive sleep apnea and subclinical carotid atherosclerosis in patients without overt cardiovascular disease. Eur Respir J 2016; 48: Suppl. 60, 2301

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence and severity of obstructive sleep apnea syndrome in patients with atherosclerosis: A study using carotid ultrasonography and coronary angiography
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


Determinants of subclinical atherosclerosis in patients with obstructive sleep apnoea
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015


The relationship between the severity of obstructive sleep apnea syndrome and severity of chronic obstructive pulmonary disease (COPD) associated with coronary artery disease (CAD)
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016

Early signs of cardiovascular system dysfunction in obstructive sleep apnea (OSA) patients before clinical manifestation
Source: Annual Congress 2009 - Cardiovascular complications in obstructive sleep apnoea
Year: 2009

Use of clinical predictors on diagnosis of OSAS in patients with chronic obstructive pulmonary disease, asthma and cardiovascular diseases
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014


Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006

Association between coronary artery disease (CAD) and heart failure and age in obstructive sleep apnoea (OSA) patients
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014

Albuminuria in moderate and severe obstructive sleep apnoea (OSA) patients
Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Year: 2015

Relationship of obstructive sleep apnoea severity and subclinical systemic atherosclerosis
Source: Eur Respir J, 55 (2) 1900959; 10.1183/13993003.00959-2019
Year: 2020



Progression of subclinical atherosclerosis in obstructive sleep apnoea (OSA)
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016

The effect of physical rehabilitation (PR) on the severity of symptoms of OSAS in patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea syndrome (OSA)
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016


Effect of positive airway pressure on diastolic function in coronary artery disease patients with non-sleepy obstructive sleep apnea
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016


Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 593s
Year: 2007

The clinical presentation of obstructive sleep apnea syndrome is different in diabetic patients
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016

Autoantibody against NBL1 in obstructive sleep apnea patients with cardiovascular disease
Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea
Year: 2017



Subclinical atherosclerosis in obstructive sleep apnea (OSA): The EPIOSA study
Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine
Year: 2015

Prevalence of stroke in obstructive sleep apnoea (OSA) patients
Source: Eur Respir J 2007; 30: Suppl. 51, 331s
Year: 2007

Prevalence of cardiorespiratory disease increase with increasing severity of obstructive sleep apnoea (OSA)
Source: Eur Respir J 2002; 20: Suppl. 38, 322s
Year: 2002

Prevalence of co-morbidities and clinical features in patients with obstructive sleep apnea and chronic obstructive pulmonary disease.
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018

Investigation of the prevalence of obstructive sleep apnea syndrome in patients with diagnosed subclinicalhypothyroidism
Source: Sleep and Breathing Conference 2021
Year: 2021